InvestSMART

Avecho Biotechnology Limited (ASX: AVE) - Announcements

- Current share price for AVE : $0.020

ASX company news and announcements for Avecho Biotechnology Limited (AVE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Avecho Biotechnology Limited (AVE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Avecho Biotechnology Limited (AVE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Avecho Biotechnology Limited (AVE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$77 Small Holding Share Sale Facility Completion 12 Aug 2026 10:02AM $0.021 $0.020 fallen by 4.76%
$77 Japanese patent granted for CBD capsule 3 Aug 2026 9:48AM $0.019 $0.020 risen by 5.26%
$77 June 2026 Quarterly Activities Report & Appendix 4C 29 Jul 2026 9:43AM $0.021 $0.020 fallen by 4.76%
$77 Application for quotation of securities - AVE 30 Jun 2026 4:06PM $0.024 $0.020 fallen by 16.67%
$77 Positive Phase III Interim Analysis Results Investor Webinar 24 Jun 2026 9:01AM $0.015 $0.020 risen by 33.33%
$77 Positive interim results from Phase III insomnia program 24 Jun 2026 8:50AM $0.015 $0.020 risen by 33.33%
$77 Phase III Interim Analysis Outcome Webinar 23 Jun 2026 9:19AM $0.015 $0.020 risen by 33.33%
$77 Trading Halt 22 Jun 2026 8:31AM $0.015 $0.020 risen by 33.33%
$77 Notification regarding unquoted securities - AVE 2 Jun 2026 4:24PM $0.012 $0.020 risen by 66.67%
$77 Notification of cessation of securities - AVE 1 Jun 2026 9:22AM $0.012 $0.020 risen by 66.67%
$77 Final Director's Interest Notice 1 Jun 2026 9:22AM $0.012 $0.020 risen by 66.67%
$77 Small Holding Share Sale Facility 27 May 2026 9:55AM $0.013 $0.020 risen by 53.85%
$77 2026 Annual General Meeting Results 26 May 2026 2:53PM $0.013 $0.020 risen by 53.85%
$77 Chair's Address and CEO Presentation 26 May 2026 11:38AM $0.013 $0.020 risen by 60%
$77 Resignation of Non-Executive Director 25 May 2026 4:00PM $0.012 $0.020 risen by 66.67%
$77 Investor Webinar Presentation 25 May 2026 10:24AM $0.012 $0.020 risen by 66.67%
$77 Receipt of Research & Development Tax Incentive 22 May 2026 9:41AM $0.012 $0.020 risen by 66.67%
$77 Avecho completes treatment for Phase III interim analysis 21 May 2026 10:16AM $0.013 $0.020 risen by 60%
$77 Change of Director's Interest Notice x3 13 May 2026 4:15PM $0.013 $0.020 risen by 53.85%
$77 Application for quotation of securities - AVE 13 May 2026 3:53PM $0.014 $0.020 risen by 48.15%
$77 Expiry of Listed Options 12 May 2026 10:54AM $0.013 $0.020 risen by 53.85%
$77 Application for quotation of securities - AVE 7 May 2026 11:51AM $0.012 $0.020 risen by 66.67%
$77 Change of Company Secretary 1 May 2026 2:39PM $0.012 $0.020 risen by 66.67%
$77 Letter to Optionholders - Notice of Expiry of Listed Options 29 Apr 2026 2:13PM $0.011 $0.020 risen by 81.82%
$77 March 2026 Quarterly Activities Report & Appendix 4C 29 Apr 2026 8:33AM $0.011 $0.020 risen by 81.82%

1 - 25 of 312 results

Page 1 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.